Testing the effects of FSHD candidate gene expression in vertebrate muscle development

International Journal of Clinical and Experimental Pathology

Volumn 3, Issue 4, 2010, Pages 386-400

  Wuebbles, Ryan D ^a,b   Long, Steven W ^a   Hanel, Meredith L ^a   Jones, Peter L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

DUX4; DUX4c; Facioscapulohumeral muscular dystrophy; FRG1; FSHD; PITX1

Indexed keywords

DUX4 PROTEIN, HUMAN; FRG1 PROTEIN, XENOPUS; HOMEOBOX PROTEIN PITX1; HOMEODOMAIN PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; XENOPUS PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MUSCLE; MUSCLE DEVELOPMENT; NICK END LABELING; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; XENOPUS LAEVIS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCLES; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PAIRED BOX TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 77955892276     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Fitzsimons RB, Gurwin EB and Bird AC. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 1987; 110 (Pt 3): 631-648.
2. Padberg GW, Brouwer OF, de Keizer RJ, Dijkman G, Wijmenga C, Grote JJ and Frants RR. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 1995; 2: S73-80.
3. van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, van Ommen GJ, Hofker MH and Frants RR. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993; 2: 2037-2042.
4. Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, Gruter AM, Hofker MH, Moerer P, Williamson R and et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992; 2: 26-30.
5. van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR and van der Maarel SM. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003; 35: 315-317.
6. Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Matteotti C, van Acker AM, Leo O, Figlewicz D, Barro M, Laoudj-Chenivesse D, Belayew A, Coppee F and Chen YW. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 2007; 104: 18157-18162.
7. Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, Green MR and Tupler R. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006; 439: 973-977.
8. Gabellini D, Green MR and Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002; 110: 339-348.
9. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S and Ehrlich M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003; 12: 2909-2921.
10. Rijkers T, Deidda G, van Koningsbruggen S, van Geel M, Lemmers RJ, van Deutekom JC, Figlewicz D, Hewitt JE, Padberg GW, Frants RR and van der Maarel SM. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet 2004; 41: 826-836.
11. Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, van der Maarel SM, Filippova GN and Tapscott SJ. RNA transcripts, miRNAsized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 2009; 18: 2414-2430.
12. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y and Flanigan KM. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 2003; 12: 2895-2907.
13. Klooster R, Straasheijm K, Shah B, Sowden J, Frants R, Thornton C, Tawil R and van der Maarel S. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur J Hum Genet 2009; 17: 1615-1624.
14. Barro M, Carnac G, Flavier S, Mercier J, Vassetzky Y and Laoudj-Chenivesse D. Myoblasts from affected and non affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med 2008;
15. Bodega B, Ramirez GD, Grasser F, Cheli S, Brunelli S, Mora M, Meneveri R, Marozzi A, Mueller S, Battaglioli E and Ginelli E. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol 2009; 7: 41.
16. Morosetti R, Mirabella M, Gliubizzi C, Broccolini A, Sancricca C, Pescatori M, Gidaro T, Tasca G, Frusciante R, Tonali PA, Cossu G and Ricci E. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 2007; 25: 3173-3182.
17. Hanel ML, Wuebbles RD and Jones PL. Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev Dyn 2009; 238: 1502-1512.
18. Wuebbles RD, Hanel ML and Jones PL. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis Model Mech 2009; 2: 267-274.
19. Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Matteotti C, Arias C, Corona ED, Nunez NG, Leo O, Wattiez R, Figlewicz D, Laoudj-Chenivesse D, Belayew A, Coppee F and Rosa AL. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 2007; 17: 611-623.
20. Ansseau E, Laoudj-Chenivesse D, Marcowycz A, Tassin A, Vanderplanck C, Sauvage S, Barro M, Mahieu I, Leroy A, Leclercq I, Mainfroid V, Figlewicz D, Mouly V, Butler-Browne G, Belayew A and Coppee F. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One 2009; 4: e7482.
21. Gabriels J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D and Belayew A. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999; 236: 25-32.
22. Wright TJ, Wijmenga C, Clark LN, Frants RR, Williamson R and Hewitt JE. Fine mapping of the FSHD gene region orientates the rearranged fragment detected by the probe p13E-11. Hum Mol Genet 1993; 2: 1673-1678.
23. Winokur ST, Bengtsson U, Vargas JC, Wasmuth JJ, Altherr MR, Weiffenbach B and Jacobsen SJ. The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region. Hum Mol Genet 1996; 5: 1567-1575.
24. Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppee F, Belayew A, Perlingeiro RR and Kyba M. An isogenetic myoblast expression screen identifies DUX4-mediated FSHDassociated molecular pathologies. EMBO J 2008; 27: 2766-2779.
25. Bosnakovski D, Lamb S, Simsek T, Xu Z, Belayew A, Perlingeiro R and Kyba M. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol 2008;
26. Hensey C and Gautier J. A developmental timer that regulates apoptosis at the onset of gastrulation. Mech Dev 1997; 69: 183-195.
27. Harland RM. In situ hybridization: an improved whole-mount method for Xenopus embryos. Methods Cell Biol 1991; 36: 685-695.
28. Nieuwkoop PD and Faber J. Normal table of Xenopus laevis (Daudin): a systematical and chronological survey of the development from the fertilized egg till the end of metamorphosis. New York: Garland Pub., 1994.
29. Chang W, KhosrowShahian F, Chang R and Crawford MJ. xPitx1 plays a role in specifying cement gland and head during early Xenopus development. Genesis 2001; 29: 78-90.
30. Reed PW, Corse AM, Porter NC, Flanigan KM and Bloch RJ. Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol 2007; 205: 583-586.
31. Bosnakovski D, Daughters RS, Xu Z, Slack JM and Kyba M. Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHDrelated repeats. PLoS One 2009; 4: e7003.
32. Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, Armour JA and Hewitt JE. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81: 264-279.
33. Kawazu M, Yamamoto G, Yoshimi M, Yamamoto K, Asai T, Ichikawa M, Seo S, Nakagawa M, Chiba S, Kurokawa M and Ogawa S. Expression profiling of immature thymocytes revealed a novel homeobox gene that regulates doublenegative thymocyte development. J Immunol 2007; 179: 5335-5345.
34. Wu SL, Tsai MS, Wong SH, Hsieh-Li HM, Tsai TS, Chang WT, Huang SL, Chiu CC and Wang SH. Characterization of genomic structures and expression profiles of three tandem repeats of a mouse double homeobox gene: Duxbl. Dev Dyn
35. Bopp D, Burri M, Baumgartner S, Frigerio G and Noll M. Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. Cell 1986; 47: 1033-1040.
36. Finkelstein R, Smouse D, Capaci TM, Spradling AC and Perrimon N. The orthodenticle gene encodes a novel homeo domain protein involved in the development of the Drosophila nervous system and ocellar visual structures. Genes Dev 1990; 4: 1516-1527.
37. Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, van Deutekom JC, Francis F, Sharpe PT, Hofker M and et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994; 3: 1287-1295.
38. Simeone A, Puelles E and Acampora D. The Otx family. Curr Opin Genet Dev 2002; 12: 409-415.
39. Buckingham M. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 2006; 16: 525-532.
40. Olguin HC and Olwin BB. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for selfrenewal. Dev Biol 2004; 275: 375-388.
41. Relaix F, Montarras D, Zaffran S, Gayraud-Morel B, Rocancourt D, Tajbakhsh S, Mansouri A, Cumano A and Buckingham M. Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J Cell Biol 2006; 172: 91-102.
42. Tajbakhsh S, Rocancourt D, Cossu G and Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 1997; 89: 127-138.
43. Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, Chung SA, Masny PS and Figlewicz DA. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord 2003; 13: 322-333.
44. Sandri M, El Meslemani AH, Sandri C, Schjerling P, Vissing K, Andersen JL, Rossini K, Carraro U and Angelini C. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 2001; 60: 302-312.
45. Tremblay JJ, Goodyer CG and Drouin J. Transcriptional properties of Ptx1 and Ptx2 isoforms. Neuroendocrinology 2000; 71: 277-286.
46. Lanctot C, Moreau A, Chamberland M, Tremblay ML and Drouin J. Hindlimb patterning and mandible development require the Ptx1 gene. Development 1999; 126: 1805-1810.
47. Szeto DP, Rodriguez-Esteban C, Ryan AK, O'Connell SM, Liu F, Kioussi C, Gleiberman AS, Izpisua-Belmonte JC and Rosenfeld MG. Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev 1999; 13: 484-494.
48. Logan M and Tabin CJ. Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity. Science 1999; 283: 1736-1739.
49. Cole NJ, Tanaka M, Prescott A and Tickle C. Expression of limb initiation genes and clues to the morphological diversification of threespine stickleback. Curr Biol 2003; 13: R951-952.
50. Shapiro MD, Marks ME, Peichel CL, Blackman BK, Nereng KS, Jonsson B, Schluter D and Kingsley DM. Genetic and developmental basis of evolutionary pelvic reduction in threespine sticklebacks. Nature 2004; 428: 717-723.
51. Tanaka M, Hale LA, Amores A, Yan YL, Cresko WA, Suzuki T and Postlethwait JH. Developmental genetic basis for the evolution of pelvic fin loss in the pufferfish Takifugu rubripes. Dev Biol 2005; 281: 227-239.
52. Hollemann T and Pieler T. Xpitx-1: a homeobox gene expressed during pituitary and cement gland formation of Xenopus embryos. Mech Dev 1999; 88: 249-252.
53. Schweickert A, Deissler K, Blum M and Steinbeisser H. Pitx1 and Pitx2c are required for ectopic cement gland formation in Xenopus laevis. Genesis 2001; 30: 144-148.
54. Liu DX and Lobie PE. Transcriptional activation of p53 by Pitx1. Cell Death Differ 2007; 14: 1893-1907.